Lorient Pharma Private Limited
About Lorient Pharma Private Limited
Data last updated:
Lorient Pharma Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 11 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51109BR2016PTC025966. Its GSTIN is 10AADCL0199B1Z5 (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.5 Lakh. It is led by directors Pritam Kumar Sinha (Whole-Time Director) and Shailesh Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R/F – 171 Housing Colony Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.23 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹32,281 (net margin 1.9%) and EBITDA of ₹35,147 (EBITDA margin 2%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lorient Pharma Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressR/F – 171 Housing Colony Kankarbagh, Patna, Bihar, India – 800020
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Lorient Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lorient Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lorient Pharma Private Limited, buy the company report.
Financials of Lorient Pharma Private Limited
FY 2025 filings availableLorient Pharma Private Limited reported revenue of ₹17.23 Lakh (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 10% fall in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35,147 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32,281 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lorient Pharma Private Limited, buy the company report.
Board of directors of Lorient Pharma Private Limited
Lorient Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pritam Kumar Sinha | Whole-Time Director | 11 Feb 2016 | 10 Years 8 Months | Current |
| Shailesh Kumar | Whole-Time Director | 11 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Lorient Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Believe in Hope (OPC) Private Limited | ₹17.24 Lakh (FY 2023) | -68.0% | Chandigarh, India | |||
| Mountain Buildwell Private Limited | ₹17.24 Lakh (FY 2025) | -13.0% | New Delhi, Delhi, India | |||
| Jessica Creations Private Limited | ₹17.23 Lakh (FY 2020) | -44.0% | New Delhi, Delhi, India | |||
| Kari Juno Fashions Private Limited | ₹17.23 Lakh (FY 2022) | -10.0% | Ernakulam, Kerala, India | |||
| M D Plasto Industries Private Limited | ₹17.23 Lakh (FY 2023) | -65.0% | Aurangabad, Maharashtra, India | |||
| Lorient Pharma Private Limitedthis company | ₹17.23 Lakh (FY 2025) | ₹32,281 | 1.9% | -10.0% | Patna, Bihar, India | |
| Shree Paanking Gruh Udhog Private Limited | ₹17.23 Lakh (FY 2024) | Vadodara, Gujarat, India | ||||
| Cronus Agritech Private Limited | ₹17.22 Lakh (FY 2021) | -65.0% | Bhopal, Madhya Pradesh, India | |||
| Nagar Farmer Producer Company Limited | ₹17.22 Lakh (FY 2025) | 7.0% | Osmanabad, Maharashtra, India | |||
| Seven Elements Exports Private Limited | ₹17.22 Lakh (FY 2022) | 202.0% | Nashik, Maharashtra, India | |||
| Imkemex International Private Limited | ₹17.21 Lakh (FY 2016) | -73.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Lorient Pharma Private Limited, buy the company report.
Auditor
Lorient Pharma Private Limited is audited by S.N.MISHRA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.N.MISHRA & ASSOCIATES | FY 2017 | 005097C |
Shareholding
The shareholding of Lorient Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Lorient Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lorient Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lorient Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lorient Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCL0199B1Z5 | Bihar | Active | 31 Jan 2019 |
To see the full GST registrations and return filing status of Lorient Pharma Private Limited, buy the company report.
Recent activity
Lorient Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Prabha Singh ceased to be Director on 16 Nov 2022.
Frequently asked questions
Lorient Pharma is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 11 February 2016 (10+ years old) and is registered under CIN U51109BR2016PTC025966.
Lorient Pharma has 2 current directors:
- Pritam Kumar Sinha - Whole-Time Director
- Shailesh Kumar - Whole-Time Director
The latest financial statements of Lorient Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Lorient Pharma is 10AADCL0199B1Z5, registered in Bihar.
The CIN (Corporate Identification Number) of Lorient Pharma is U51109BR2016PTC025966. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lorient Pharma was incorporated on 11 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Lorient Pharma by revenue are Believe in Hope (OPC) Private Limited, Mountain Buildwell Private Limited, Jessica Creations Private Limited, Kari Juno Fashions Private Limited, M D Plasto Industries Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Prabha Singh ceased to be Director on 16 Nov 2022. Pritam Kumar Sinha was appointed as Whole-Time Director on 11 Feb 2016. Shailesh Kumar was appointed as Whole-Time Director on 11 Feb 2016.
The registered office of Lorient Pharma is at RF – 171 Housing Colony Kankarbagh, Patna, Bihar, India – 800020.
Lorient Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Lorient Pharma is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.